The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Clinical aspects and molecular basis of oxaliplatin neurotoxicity: Current management and development of preventive measures
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ionic channels of excitable membranes
(1985) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(85)90172-7 · Cited by 6,982
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815
Browne, D. L., Gancher, S. T., Nutt, J. G., Brunt, E. R. P., Smith, E. A., Kramer, P., & Litt, M. (1994) · Nature Genetics · doi:10.1038/ng1094-136 · Cited by 777
Antiepileptic Drug Mechanisms of Action
Macdonald, R. L., & Kelly, K. M. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb05996.x · Cited by 591
Waxman, S. G., Kocsis, J. D., & Black, J. A. (1994) · Journal of Neurophysiology · doi:10.1152/jn.1994.72.1.466 · Cited by 552
Voltage-Gated Ion Channels and Hereditary Disease
Lehmann-Horn, F., & Jurkat-Rott, K. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1317 · Cited by 550
Mitochondrial Participation in Ischemic and Traumatic Neural Cell Death
FISKUM, G. (2000) · Journal of Neurotrauma · doi:10.1089/neu.2000.17.843 · Cited by 346
Grolleau, F., Gamelin, L., Boisdron-Celle, M., Lapied, B., Pelhate, M., & Gamelin, E. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.5.2293 · Cited by 344
Self-citationPhase I study of oxaliplatin in patients with advanced cancer
Extra, J. M., Espie, M., Calvo, F., Ferme, C., Mignot, L., & Marty, M. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00684890 · Cited by 343
Felts, P. A., Yokoyama, S., Dib-Hajj, S., Black, J. A., & Waxman, S. G. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00241-0 · Cited by 333
Oxaliplatin-Induced Damage of Cellular DNA
Woynarowski, J. M., Faivre, S., Herzig, M. C. S., Arnett, B., Chapman, W. G., Trevino, A. V., Raymond, E., Chaney, S. G., Vaisman, A., Varchenko, M., et al. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12463-7 · Cited by 310
The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons
Adelsberger, H., Quasthoff, S., Grosskreutz, J., Lepier, A., Eckel, F., & Lersch, C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00667-1 · Cited by 290
Self-citationDib-Hajj, S. D., Fjell, J., Cummins, T. R., Zheng, Z., Fried, K., LaMotte, R., Black, J. A., & Waxman, S. G. (1999) · Pain · doi:10.1016/s0304-3959(99)00169-4 · Cited by 286
Gill, J. S., & Windebank, A. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1130 · Cited by 278
André, T., Bensmaine, M. A., Louvet, C., François, E., Lucas, V., Desseigne, F., Beerblock, K., Bouché, O., Carola, E., Merrouche, Y., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3560 · Cited by 277
Hyperexcitability at sites of nerve injury depends on voltage-sensitive Na+ channels
Matzner, O., & Devor, M. (1994) · Journal of Neurophysiology · doi:10.1152/jn.1994.72.1.349 · Cited by 272
Lajer, H., & Daugaard, G. (1999) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0097 · Cited by 250
Pearn, J. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.1.4 · Cited by 220
Carboplatin: the clinical spectrum to date
Canetta, R., Rozencweig, M., & Carter, S. K. (1985) · Cancer Treatment Reviews · doi:10.1016/0305-7372(85)90027-1 · Cited by 197
Neurotoxicity secondary to antineoplastic drugs
Tuxen, M. K., & Hansen, S. W. (1994) · Cancer Treatment Reviews · doi:10.1016/0305-7372(94)90027-2 · Cited by 167
Omaña-Zapata, I., Khabbaz, M. A., Hunter, J. C., Clarke, D. E., & Bley, K. R. (1997) · Pain · doi:10.1016/s0304-3959(97)00012-2 · Cited by 123
Honmou, O., Kocsis, J. D., & Richerson, G. B. (1995) · Epilepsy Research · doi:10.1016/0920-1211(94)00076-9 · Cited by 85
Krarup‐Hansen, Rietz, Krarup, Heydorn, Rørth, & Schmalbruch (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00160.x · Cited by 82
Mechanisms of paresthesias arising from healthy axons
Mogyoros, I., Bostock, H., & Burke, D. J. (2000) · Muscle & Nerve · Cited by 79
Luo, F., Wyrick, S. D., & Chaney, S. G. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050941 · Cited by 69
Sodium Channels and Therapy of Central Nervous System Diseases
Taylor, C. P., & Narasimhan, L. S. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60069-1 · Cited by 63
Axonal channelopathies: An evolving concept in the pathogenesis of peripheral nerve disorders
Gutmann, L., & Gutmann, L. (1996) · Neurology · doi:10.1212/wnl.47.1.18 · Cited by 50
Pathogenic autoantibodies to neuronal proteins in neurological disorders
Vincent, A. C., Lily, O., & Palace, J. A. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00210-6 · Cited by 45
Carbamazepine versus Diphenylhydantoin in the Treatment of Myotonia
Sechi, G., Traccis, S., Durelli, L., Monaco, F., & Mutani, R. (2008) · European Neurology · doi:10.1159/000115546 · Cited by 41
Ion Channel Mutations and Diseases of Skeletal Muscle
Barchi, R. L. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0158 · Cited by 32
Neurological diseases caused by ion-channel mutations
Weinreich, F., & Jentsch, T. J. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00089-1 · Cited by 30
Elliott, J. R. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00072-3 · Cited by 26
Lu, C., Fu, W., & Mattson, M. P. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0377 · Cited by 26
The Use of Anticonvulsants in Neurological Conditions Other Than Epilepsy
Beghi, E. (1999) · CNS Drugs · doi:10.2165/00023210-199911010-00006 · Cited by 11
Cited by
Cancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066
Chemotherapy‐induced neuropathy
Windebank, A. J., & Grisold, W. (2008) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2008.00156.x · Cited by 613
Diagnosis, Management, and Evaluation of Chemotherapy-Induced Peripheral Neuropathy
Hausheer, F. H., Schilsky, R. L., Bain, S., Berghorn, E. J., & Lieberman, F. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.12.010 · Cited by 408
Pollutants released from the pulp paper industry: Aquatic toxicity and their health hazards
Singh, A. K., & Chandra, R. (2019) · Aquatic Toxicology · doi:10.1016/j.aquatox.2019.04.007 · Cited by 348
Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature
Argyriou, A., Kyritsis, A., Makatsoris, T., & Kalofonos, H. (2014) · Cancer Management and Research · doi:10.2147/cmar.s44261 · Cited by 273
Metadata
- Authors
- Gamelin, E., Gamelin, L., Bossi, L., & Quasthoff, S.
- Venue
- Seminars in Oncology
- Publisher
- Elsevier BV
- Published
- 2002-10
- Volume
- 29
- Issue
- 5 Suppl 15
- Pages
- 21-33
- ISSN
- 0093-7754 (ISSN-L)
- OpenAlex
- W2011665876
- Cited by
- 321
- References
- 34
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.